共 50 条
- [43] Use of Erythropoietin-Stimulating Agents (ESA) in Patients With End-Stage Renal Failure Decided to Forego Dialysis: Palliative Perspective AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2017, 34 (04): : 380 - 384
- [46] Development of Artificial Intelligence for Clinical Decision Support to Optimizes Erythropoietin-Stimulating Agents in Patients with CKD JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):